🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › California › Mountain View

Uji klinis Leukemia Mieloid Akut di Mountain View, CA

19 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Menerima pesertaFase 1
  • Lucile Packard Children's Hospital /ID# 276015, Palo Alto · 5 mi jauhnya
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07306832

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Menerima pesertaFase 1
  • Stanford Health Care, Stanford · 5 mi jauhnya
Usia 12 hingga 78 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Menerima pesertaFase 3
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi jauhnya
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Menerima pesertaFase 2
  • Stanford Cancer Institute, Stanford · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Menerima pesertaFase 1/2
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi jauhnya
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Menerima pesertaFase 1
  • Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi jauhnya
18 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07573111

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Menerima pesertaFase 1
  • Stanford University, Palo Alto · 5 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07302776

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Menerima pesertaFase 1
  • Stanford University, Palo Alto · 5 mi jauhnya
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05188170

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Stanford University Medical Center, Stanford · 5 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Menerima pesertaFase 1
  • Stanford University, Palo Alto · 5 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06551584

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Menerima pesertaFase 1
  • Stanford University, Stanford · 5 mi jauhnya
Hingga usia 21 · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT05101551

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

Menerima pesertaFase 1/2
  • Stanford University, Palo Alto · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT06561152

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Menerima pesertaFase 1/2
  • Stanford University, Palo Alto · 5 mi jauhnya
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04988555

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Menerima pesertaFase 1
  • Stanford Medical Center, Palo Alto · 5 mi jauhnya
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT06994676

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Menerima pesertaFase 1
  • Stanford University, Stanford · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT06950034

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Menerima pesertaFase 1
  • Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT06501196

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1/2
  • Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2025 · NCT03850574

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Menerima pesertaSukarelawan sehat diterima
  • Stanford University, Stanford · 5 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 25 Jul 2025 · NCT05237258

Uji klinis Leukemia Mieloid Akut di kota lain

Studi lain di Mountain View

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.